Logo image of FIVE

FIVE BELOW (FIVE) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:FIVE - US33829M1018 - Common Stock

189.89 USD
+1.22 (+0.65%)
Last: 12/26/2025, 8:00:00 PM
187.7 USD
-2.19 (-1.15%)
After Hours: 12/26/2025, 8:00:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to FIVE. FIVE was compared to 123 industry peers in the Specialty Retail industry. FIVE has an excellent financial health rating, but there are some minor concerns on its profitability. FIVE shows excellent growth, but is valued quite expensive already. These ratings could make FIVE a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year FIVE was profitable.
FIVE had a positive operating cash flow in the past year.
Each year in the past 5 years FIVE has been profitable.
Each year in the past 5 years FIVE had a positive operating cash flow.
FIVE Yearly Net Income VS EBIT VS OCF VS FCFFIVE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

1.2 Ratios

FIVE's Return On Assets of 6.43% is fine compared to the rest of the industry. FIVE outperforms 76.42% of its industry peers.
FIVE has a better Return On Equity (15.79%) than 73.98% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.99%, FIVE is in the better half of the industry, outperforming 68.29% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for FIVE is below the industry average of 12.17%.
Industry RankSector Rank
ROA 6.43%
ROE 15.79%
ROIC 7.99%
ROA(3y)7.16%
ROA(5y)7.3%
ROE(3y)17.41%
ROE(5y)18.22%
ROIC(3y)8.48%
ROIC(5y)9.59%
FIVE Yearly ROA, ROE, ROICFIVE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

With an excellent Profit Margin value of 6.96%, FIVE belongs to the best of the industry, outperforming 82.11% of the companies in the same industry.
In the last couple of years the Profit Margin of FIVE has declined.
The Operating Margin of FIVE (8.88%) is better than 78.86% of its industry peers.
FIVE's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 35.63%, FIVE is in line with its industry, outperforming 47.15% of the companies in the same industry.
In the last couple of years the Gross Margin of FIVE has remained more or less at the same level.
Industry RankSector Rank
OM 8.88%
PM (TTM) 6.96%
GM 35.63%
OM growth 3Y-21.23%
OM growth 5Y-6.62%
PM growth 3Y-12.57%
PM growth 5Y-7.15%
GM growth 3Y-1.19%
GM growth 5Y-0.89%
FIVE Yearly Profit, Operating, Gross MarginsFIVE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

7

2. Health

2.1 Basic Checks

FIVE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, FIVE has less shares outstanding
The number of shares outstanding for FIVE has been reduced compared to 5 years ago.
FIVE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
FIVE Yearly Shares OutstandingFIVE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
FIVE Yearly Total Debt VS Total AssetsFIVE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 4.09 indicates that FIVE is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 4.09, FIVE belongs to the best of the industry, outperforming 82.93% of the companies in the same industry.
There is no outstanding debt for FIVE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.09
ROIC/WACC0.84
WACC9.56%
FIVE Yearly LT Debt VS Equity VS FCFFIVE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

FIVE has a Current Ratio of 1.60. This is a normal value and indicates that FIVE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.60, FIVE is in the better half of the industry, outperforming 65.04% of the companies in the same industry.
FIVE has a Quick Ratio of 1.60. This is a bad value and indicates that FIVE is not financially healthy enough and could expect problems in meeting its short term obligations.
FIVE has a Quick ratio (0.59) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.6
Quick Ratio 0.59
FIVE Yearly Current Assets VS Current LiabilitesFIVE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

7

3. Growth

3.1 Past

FIVE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.90%, which is quite good.
The Earnings Per Share has been growing by 10.07% on average over the past years. This is quite good.
FIVE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.78%.
The Revenue has been growing by 15.99% on average over the past years. This is quite good.
EPS 1Y (TTM)11.9%
EPS 3Y0.6%
EPS 5Y10.07%
EPS Q2Q%61.9%
Revenue 1Y (TTM)15.78%
Revenue growth 3Y10.82%
Revenue growth 5Y15.99%
Sales Q2Q%23.06%

3.2 Future

The Earnings Per Share is expected to grow by 30.76% on average over the next years. This is a very strong growth
Based on estimates for the next years, FIVE will show a quite strong growth in Revenue. The Revenue will grow by 16.48% on average per year.
EPS Next Y18.26%
EPS Next 2Y13%
EPS Next 3Y12.42%
EPS Next 5Y30.76%
Revenue Next Year20.09%
Revenue Next 2Y14.85%
Revenue Next 3Y12.81%
Revenue Next 5Y16.48%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
FIVE Yearly Revenue VS EstimatesFIVE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B
FIVE Yearly EPS VS EstimatesFIVE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5 10 15 20

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 32.57 indicates a quite expensive valuation of FIVE.
FIVE's Price/Earnings ratio is in line with the industry average.
FIVE's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 26.57.
FIVE is valuated quite expensively with a Price/Forward Earnings ratio of 29.51.
Compared to the rest of the industry, the Price/Forward Earnings ratio of FIVE is on the same level as its industry peers.
FIVE's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 24.04.
Industry RankSector Rank
PE 32.57
Fwd PE 29.51
FIVE Price Earnings VS Forward Price EarningsFIVE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as FIVE.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of FIVE is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 32.43
EV/EBITDA 16.8
FIVE Per share dataFIVE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
FIVE has a very decent profitability rating, which may justify a higher PE ratio.
FIVE's earnings are expected to grow with 12.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.78
PEG (5Y)3.24
EPS Next 2Y13%
EPS Next 3Y12.42%

0

5. Dividend

5.1 Amount

No dividends for FIVE!.
Industry RankSector Rank
Dividend Yield 0%

FIVE BELOW

NASDAQ:FIVE (12/26/2025, 8:00:00 PM)

After market: 187.7 -2.19 (-1.15%)

189.89

+1.22 (+0.65%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)12-03 2025-12-03/amc
Earnings (Next)06-02 2026-06-02
Inst Owners107.97%
Inst Owner Change-2.51%
Ins Owners0.97%
Ins Owner Change-2.62%
Market Cap10.47B
Revenue(TTM)4.43B
Net Income(TTM)307.87M
Analysts74.19
Price Target191 (0.58%)
Short Float %4.98%
Short Ratio2.04
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)101.66%
Min EPS beat(2)29.03%
Max EPS beat(2)174.29%
EPS beat(4)4
Avg EPS beat(4)51.97%
Min EPS beat(4)1.27%
Max EPS beat(4)174.29%
EPS beat(8)5
Avg EPS beat(8)42.48%
EPS beat(12)7
Avg EPS beat(12)29.19%
EPS beat(16)8
Avg EPS beat(16)27.52%
Revenue beat(2)2
Avg Revenue beat(2)2.62%
Min Revenue beat(2)1.37%
Max Revenue beat(2)3.87%
Revenue beat(4)2
Avg Revenue beat(4)0.63%
Min Revenue beat(4)-1.55%
Max Revenue beat(4)3.87%
Revenue beat(8)3
Avg Revenue beat(8)-0.28%
Revenue beat(12)3
Avg Revenue beat(12)-0.63%
Revenue beat(16)4
Avg Revenue beat(16)-0.91%
PT rev (1m)14.23%
PT rev (3m)17.35%
EPS NQ rev (1m)13.66%
EPS NQ rev (3m)9.73%
EPS NY rev (1m)12.99%
EPS NY rev (3m)14.45%
Revenue NQ rev (1m)3.8%
Revenue NQ rev (3m)4.33%
Revenue NY rev (1m)1.7%
Revenue NY rev (3m)2.58%
Valuation
Industry RankSector Rank
PE 32.57
Fwd PE 29.51
P/S 2.37
P/FCF 32.43
P/OCF 20.57
P/B 5.37
P/tB 5.37
EV/EBITDA 16.8
EPS(TTM)5.83
EY3.07%
EPS(NY)6.44
Fwd EY3.39%
FCF(TTM)5.86
FCFY3.08%
OCF(TTM)9.23
OCFY4.86%
SpS80.26
BVpS35.36
TBVpS35.36
PEG (NY)1.78
PEG (5Y)3.24
Graham Number68.11
Profitability
Industry RankSector Rank
ROA 6.43%
ROE 15.79%
ROCE 10.65%
ROIC 7.99%
ROICexc 9.31%
ROICexgc 9.31%
OM 8.88%
PM (TTM) 6.96%
GM 35.63%
FCFM 7.3%
ROA(3y)7.16%
ROA(5y)7.3%
ROE(3y)17.41%
ROE(5y)18.22%
ROIC(3y)8.48%
ROIC(5y)9.59%
ROICexc(3y)9.94%
ROICexc(5y)11.39%
ROICexgc(3y)9.94%
ROICexgc(5y)11.39%
ROCE(3y)11.31%
ROCE(5y)12.79%
ROICexgc growth 3Y-24.82%
ROICexgc growth 5Y-8.07%
ROICexc growth 3Y-24.82%
ROICexc growth 5Y-8.07%
OM growth 3Y-21.23%
OM growth 5Y-6.62%
PM growth 3Y-12.57%
PM growth 5Y-7.15%
GM growth 3Y-1.19%
GM growth 5Y-0.89%
F-Score9
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 98.65%
Cap/Sales 4.2%
Interest Coverage 250
Cash Conversion 87.48%
Profit Quality 104.9%
Current Ratio 1.6
Quick Ratio 0.59
Altman-Z 4.09
F-Score9
WACC9.56%
ROIC/WACC0.84
Cap/Depr(3y)229.46%
Cap/Depr(5y)263.43%
Cap/Sales(3y)8.65%
Cap/Sales(5y)9.26%
Profit Quality(3y)40.25%
Profit Quality(5y)53.87%
High Growth Momentum
Growth
EPS 1Y (TTM)11.9%
EPS 3Y0.6%
EPS 5Y10.07%
EPS Q2Q%61.9%
EPS Next Y18.26%
EPS Next 2Y13%
EPS Next 3Y12.42%
EPS Next 5Y30.76%
Revenue 1Y (TTM)15.78%
Revenue growth 3Y10.82%
Revenue growth 5Y15.99%
Sales Q2Q%23.06%
Revenue Next Year20.09%
Revenue Next 2Y14.85%
Revenue Next 3Y12.81%
Revenue Next 5Y16.48%
EBIT growth 1Y13.83%
EBIT growth 3Y-12.71%
EBIT growth 5Y8.3%
EBIT Next Year76.91%
EBIT Next 3Y29.5%
EBIT Next 5Y30.4%
FCF growth 1Y128.3%
FCF growth 3Y39.02%
FCF growth 5YN/A
OCF growth 1Y12.68%
OCF growth 3Y9.51%
OCF growth 5Y18.16%

FIVE BELOW / FIVE FAQ

What is the ChartMill fundamental rating of FIVE BELOW (FIVE) stock?

ChartMill assigns a fundamental rating of 6 / 10 to FIVE.


What is the valuation status for FIVE stock?

ChartMill assigns a valuation rating of 2 / 10 to FIVE BELOW (FIVE). This can be considered as Overvalued.


Can you provide the profitability details for FIVE BELOW?

FIVE BELOW (FIVE) has a profitability rating of 6 / 10.


How financially healthy is FIVE BELOW?

The financial health rating of FIVE BELOW (FIVE) is 7 / 10.


What is the expected EPS growth for FIVE BELOW (FIVE) stock?

The Earnings per Share (EPS) of FIVE BELOW (FIVE) is expected to grow by 18.26% in the next year.